|
|
||||||||
J Thorac Cardiovasc Surg 2002;123:98-103
© 2002 The American Association for Thoracic Surgery
Cardiothoracic Transplantation |
From the Division of Thoracic and Cardiovascular Surgerya and Department of Respiratory Medicine,b Hannover Medical School, Hannover, Germany.
Received for publication Feb 12, 2001. Revisions requested April 17, 2001; revisions received July 20, 2001. Accepted for publication July 25, 2001. Address for reprints: Martin Strüber, MD, Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Carl Neuberg Str 1, 30623 Hannover, Germany (E-mail: strueber{at}thg.mh-hannover.de).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Reperfusion injury is one of the most frequent causes of early death
1 after pulmonary allograft transplantation. The incidence of reperfusion injury has been reported to range from 20% to 40% in different lung transplant programs.
2 The requirement of extracorporal support was reported in 7.4% of 215 recipients after lung transplantation.
3 In addition, the problem of reperfusion injury led to a highly selective acceptance of pulmonary grafts: only about 10% of organ donors are considered suitable donors for pulmonary transplantation. Therefore, numerous studies have been undertaken to enhance function of the reperfused graft to improve postoperative lung function and to widen acceptance criteria for pulmonary grafts. One of the findings is the importance of endothelial and alveolar type II cell integrity after transplantation.
4 A comparison of an extracellular preservation solution, such as low-potassium dextran (LPD) solution, with the currently used solutions of intracellular ion composition (Euro-Collins, University of Wisconsin), revealed less impairment of endothelial function
5,6 and improved metabolic activity of type II pneumocytes.
7 First clinical results favor the use of LPD solution for lung preservation.
8 A different approach to improve preservation technique was the development of retrograde perfusion. In this study both developments are combined for long-term preservation (24 hours). The study was designed to compare lung function and surfactant activity after preservation with LPD solution either as an antegrade or a retrograde flush perfusion during the reperfusion period. The hypothesis of this study is a further improvement of graft function by the retrograde perfusion technique.
| Materials and methods |
|---|
|
|
|---|
Surgical preparation
Donor preparation
First group
Female pigs (22-30 kg) were anesthetized with sodium pentobarbital (10 mg/kg) and fentanyl (1 mg/kg followed by a fentanyl infusion of 1 mg · kg1 · h1). The animals were intubated and ventilated with 100% of oxygen (inspiratory/expiratory ratio = 1:1, positive end-expiratory pressure = 5 mm Hg) in a pressure-controlled mode with a maximum airway pressure of 20 mm Hg and a ventilation rate of 10 breaths/min. A median sternotomy was performed and the pericardium was cut open. A catheter to infuse preservation solution was inserted into the main pulmonary artery. Heparin (3 mg/kg) was administered intravenously. Cardiac arrest was induced by clamping of the aorta and cardioplegic solution was infused into the aortic root. The venae cavae vere clamped. Thereafter, the auricle of the left atrium was incised and flush perfusion of the pulmonary artery induced. In 10 minutes 1000 mL of LPD solution were administered at a temperature of 8°C. No alprostadil (prostaglandin E) infusion was used in the donor or the recipient. Ventilation of the lung was maintained through the flush procedure. The heart and lungs were excised en bloc. Care was taken to clamp the main left bronchus, leaving the left lung in a mildly inflated state. The left lung was isolated from the heart-lung block with a generous atrial cuff and full length of both the pulmonary artery and main bronchus. The lung was stored at 4°C for 24 hours.
Second group
The preparation was identical but for the perfusion procedure. A 2-lumen catheter to infuse LPD solution and to measure left atrial pressure was placed at the auricle into the left atrium and tied. After cardiac arrest and clamping of the venae cavae, perfusion was started in a retrograde fashion and was drained through an incision of the main pulmonary artery. Care was taken not to exceed a left atrial pressure of 12 mm Hg. A 10-minute period was required to infuse 1000 mL of LPD solution. Ventilation was maintained though the perfusion procedure.
Recipient preparation
Female pigs (22-30 kg) were anesthetized with sodium pentobarbital (10 mg/kg) and fentanyl (1 mg/kg, followed by a fentanyl infusion of 1 mg · kg1 · h1). The animals were intubated and ventilated with 50% oxygen (inspiratory/expiratory ratio = 1:1, positive end-expiratory pressure = 5 mm Hg) in a pressure-controlled mode (frequency = 10 breaths/min, maximum pressure = 20 mm Hg). A Swan-Ganz catheter (7.5F; Baxter Healthcare Corp, Irvine, Calif) and a catheter to monitor arterial pressure were placed into the right carotid artery and internal jugular vein, respectively. A catheter for monitoring of the extravascular lung water was inserted into a femoral artery. A left thoracotomy in the fifth intercostal space was performed, and the pericardium was opened. The left pulmonary artery, the tracheal bifurcation, and the pulmonary veins were dissected. Umbilical tapes were applied to the right and left pulmonary arteries and the right main bronchus. Heparin (3 mg/kg) was administered intravenously. After clamping of the left main bronchus and the left pulmonary artery, the left pulmonary veins were ligated. Pneumonectomy of the left lung was performed. A clamp was placed onto the left atrium so as to close the left pulmonary veins. The upper and lower pulmonary veins were incised with the atrial tissue between them to open an atrial cuff. Ventilation was continued and the donor lung was implanted starting with a bronchial end-to-end anastomosis with 4-0 running Prolene suture (Ethicon, Inc, Somerville, NJ). Anastomosis of the left atrial cuffs of the donor and recipient were performed followed by the left pulmonary arteries. Before reperfusion, the graft was deaired by retrograde perfusion. The pulmonary artery was unclamped and the graft ventilated. After 10 minutes of reperfusion, the right pulmonary artery and main right bronchus were clamped. Both umbilical tapes were tied. Experiments were terminated by means of a pentobarbital overdose after 7 hours of reperfusion or when systolic arterial pressure fell below 40 mm Hg. Use of inotropic substances was not permitted in the experiments.
Measurements of lung function and extravascular lung water index
In all experiments, atrial as well as arterial and pulmonary artery pressures were recorded online. Dynamic lung compliance was monitored continuously with a modified ventilator (Dräger, Lübeck, Germany). Arterial blood gas analyses were performed after placement of catheters and every 30 minutes during reperfusion. At these intervals pulmonary vascular resistance was calculated after measurement of cardiac output by means of the transfemoral thermodilution catheter, which was connected to the cardiac output computer (Picco; Pulsion Medical Systems AG, Munich, Germany). After being calibrated by injection of cold saline solution into the jugular vein, the system calculated cardiac output online by pressure curve analysis.
9 By means of the same thermal bolus injection that is distributed into intravascular blood volume and extravascular lung water, the extravascular lung water index (arithmetic value over kilograms of body weight) was computed.
10
Surfactant analysis
Bronchoalveolar lavage (BAL) fluid was obtained from the right lower lobe in all experiments after catheter placement with 100 mL of saline solution. A second BAL was performed after 2 hours of reperfusion of the left lower lobe. A differential cell count was carried out to determine the number of polymorphonuclear leukocytes as a percentage of the total cell count. The lavage was immediately centrifuged at 150g and the cell-free supernatant was frozen at 80°C. Pellet and supernatant were separated at 48,000g for 60 minutes. Protein and phospholipid content were determined. Phospholipids in the small aggregatecontaining supernatant and in the large aggregate pellet were determined by phosphorus analysis and their weight expressed as a small aggregate/large aggregate (SA/LA) ratio. The surfactant pellet was resuspended in saline solution supplemented with calcium chloride, 1.5 mmol/L. Surfactant function was determined with a pulsating bubble surfactometer (Electronetics, inc, Buffalo, NY) according to the technique described by Enhorning
11: 40 mL of large aggregate suspension, which had been adjusted to a phospholipid concentration of 1 mg/mL, was infused into the sample chamber. The surface tension at minimal bubble size (
min) was obtained after 5 minutes of bubble pulsation at a rate of 20 cycles/min and a temperature of 37°C. Before bubble pulsation was started, the initial surface tension after bubble formation was measured and the adsorption rate was determined as surface tension 10 seconds after formation of a bubble. All analog data were digitalized and recorded by a personal computer.
Animal care
All animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the Institute of Laboratory Animal Resources, National Research Council, and published by the National Academy Press, revised 1996.
Statistical analysis
All data are expressed as mean ± SE. Continuous data were analyzed by repeated-measures analysis of variance. For data without repeated measurement, analysis of variance was applied. All data were analyzed with the Statistical Program of Social Sciences (SPSS for MS Windows Version 6.1; SPSS, Inc, Chicago Ill).
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
In contrast to hundreds of articles dealing with modified composition of preservation solutions, little effort has been given to the route of administration: topical cooling was used for the first successful single lung transplants by the Toronto group.
17 Thereafter, antegrade pulmonary perfusion was established for the majority of clinical procedures.
18 However, only a few data exist regarding retrograde flush perfusion. Such a route of preservation was established for other solid organs, such as use of retrograde cardioplegia in heart surgery.
19 In an experimental study, Varela and coworkers
20 found an improvement of distribution of pulmonary flush perfusion, especially to the tracheobronchial wall, when flushing Euro-Collins solution retrogradely via the left atrium.
The aim of the present study is 2-fold: (1) to determine the effect of long-term preservation (24 hours) with LPD solution on surfactant function and (2) to define possible advantages by retrograde perfusion technique with respect to early graft and surfactant function.
A limitation of this study is the short post-transplant observation time. Results of BAL fluid and surfactant analysis represent only the early reperfusion period. The reason for early bronchoscopy was to evaluate a high number of animals, since a high survival was not expected. However, single lung transplantation with clamping of the contralateral lung is a challenging task for the preservation procedure and reveals the quality of the graft during the 4- to 6-hour reperfusion period.
21 In addition, compared with other preparations of ex vivo perfused lungs, the interaction of pulmonary circulation, reperfusion, and right-sided heart function resembles the clinical situation of single lung transplantation.
Our findings suggest that antegrade flush perfusion with LPD solution does not offer safe long-term lung preservation in the miniature pig model. Primary graft failure followed by right-sided heart failure was present in 2 of 6 experiments. In the retrogradely perfused group, oxygenation and compliance were better than in the antegradely perfused grafts. In addition, no sign of respiratory or cardiac insufficiency was seen throughout the observation period. In an earlier study, Steen and associates
21 demonstrated safe 24-hour preservation with LPD solution in a similar model using a different perfusion technique: flush perfusion with warm solution was carried out through the pulmonary and bronchial arteries followed by topical cooling of atelectatic lungs. A possible explanation of the advantage of both warm antegrade perfusion and retrograde flush is a more homogeneous distribution of the perfusion solution. Another study showed that flush perfusion via the pulmonary and bronchial arteries was associated with higher flow rates than isolated pulmonary artery perfusion or retrograde perfusion.
22 This study emphasized that distribution to the airway tissues was improved by combined pulmonary and bronchial artery perfusion. However, data on graft function were not available.
In terms of surfactant function, our study revealed a moderate impairment of surface tension in the BAL fluid of transplanted and reperfused grafts of both groups. In the antegradely perfused grafts this finding was associated with a reduction of dynamic lung compliance. In addition, SA/LA ratio was increased after reperfusion in antegradely preserved lungs, indicating a decrease of surface-active large aggregates and an increase of inactive small aggregates. In contrast, the SA/LA ratio in the retrogradely preserved group was remarkably lower. The increase of SA/LA in the antegradely perfused group reflects an accelerated conversion of surfactant aggregates into less active subtypes. This might be promoted by enzymes leaking into the alveoli during the protein-rich reperfusion edema. This hypothesis is supported by the findings of increased lung water index in the early reperfusion period and the tendency toward higher protein content of BAL fluid in this group. In addition, the finding of higher inflow of polymorphonuclear leukocytes into the airways suggests higher inflammatory activity in the reperfusion period of antegradely preserved lungs associated with an increased SA/LA conversion. The slight reduction of surfactant function in the retrogradely preserved group without concomitant increase of SA/LA ratio is suggestive of a better preservation of the surfactant system after lung transplantation. Type II pneumocytes are very susceptible to ischemic injury.
7 Therefore, a reduction of surfactant release or enhanced conversion of surfactant large aggregate to small aggregate forms may be sequelae of long-term ischemia. Additional measurements of surfactant protein levels would further enlighten our understanding of surfactant composition and function in the early reperfusion period. In animal experiments,
23,24 as well as in clinical cases,
25 early postoperative graft dysfunction was successfully improved by administration of surfactant preparations.
In summary, cold antegrade flush perfusion with LDP solution, which is the most frequent clinical application, does not reveal safe 24-hour preservation of graft and surfactant function in our experiments. In contrast, retrograde application of cold LPD solution led to appropriate initial graft function after 24 hours of ischemia with less vascular leakage and inflammatory response in the pulmonary circulation compared with antegradely perfused grafts. In addition, in this group the disturbance of surfactant was less pronounced.
Since a body of evidence has been established to prefer LPD solution in lung preservation, retrograde perfusion of this solution should be considered. Long-term preservation of the lung may impair surfactant function by ischemic injury to pneumocytes and should be avoided in clinical lung transplantation.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Struber, S. Fischer, J. Niedermeyer, G. Warnecke, B. Gohrbandt, A. Gorler, A. R. Simon, A. Haverich, and J. M. Hohlfeld Effects of exogenous surfactant instillation in clinical lung transplantation: A prospective, randomized trial J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1620 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-P. Sommer, B. Gohrbandt, S. Fischer, J. M. Hohlfeld, G. Warnecke, M. Avsar, and M. Struber Glutathione improves the function of porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 864 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. F.W. Franke, T. Wittwer, M. Lessel, K. Liebing, M. Albert, V. Becker, H. Schubert, and T. Wahlers Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: I. Influence of perfusion pressure and hyperthermia on functional and morphological lung integrity Eur. J. Cardiothorac. Surg., October 1, 2004; 26(4): 792 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Sommer, G. Warnecke, J. M. Hohlfeld, B. Gohrbandt, J. Niedermeyer, T. Kofidis, A. Haverich, and M. Struber Pulmonary preservation with LPD and celsior solution in porcine lung transplantation after 24 h of cold ischemia Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 151 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kutschka, S. P. Sommer, J. M. Hohlfeld, G. Warnecke, M. Morancho, S. Fischer, A. Haverich, M. Struber, and the Hannover Thoracic Transplant Program In-situ topical cooling of lung grafts: early graft function and surfactant analysis in a porcine single lung transplant model Eur. J. Cardiothorac. Surg., September 1, 2003; 24(3): 411 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hayama, H. Date, T. Oto, M. Aoe, A. Andou, and N. Shimizu Improved lung function by means of retrograde flush in canine lung transplantation with non-heart-beating donors J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 901 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Novick Innovative techniques to enhance lung preservation J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 3 - 5. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |